Patheon has announced Tom Sellig will be senior-vice president of global sales and Christopher Tama will be the new senior vice-president of global marketing.
These appointments are a critical step in Patheon’s ongoing sales and marketing strategic effort to drive customer growth.
Sellig’s knowledge of corporate strategic account and sales management, customer relationship management, and business partnerships regarding life science products and services is invaluable. His knowledge can support the company’s growth strategy throughout North America, Europe and Asia.
Tama will be responsible for developing high-impact marketing strategies to generate sales leads for the global pharmaceutical manufacturing company.
Pantheon president of global pharmaceutical development services Mike Lehmann said: "Tom brings more than 25 years of experience, has a reputation for results and effective leadership. Chris is known for his ability to build customer-centric strategies that drive growth and capture market share."
Sellig recently led the global clinical and market access sales and client service teams at Covance. Prior to Covance, he gained a range of experience through leadership roles at Ventana Clinical, Digitas Healthcare, Wyeth Consumer, and Procter and Gamble.
Tama joins Patheon from PAREXEL International Inc, where he transformed marketing to be a key competitive differentiator for PAREXEL. Prior to PAREXEL, Tama was unit president at Ogilvy CommonHealth and held marketing and sales leadership positions at Novartis and Pfizer.